A Clinical Study of SI-B001 in Combination With Paclitaxel in the Treatment of Recurrent and Metastatic HNSCC

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
This multi-center, open label phase II clinical study is performed in patients with relapsed metastatic head and neck squamous cell carcinoma (non-nasopharyngeal carcinoma) progressed on prior 1st or 2nd line with anti-PD-1 mab ± platinum-based chemotherapy. This study is investigating the safety and efficacy of SI-B001 at optimal combination dose with paclitaxel in patients.
Epistemonikos ID: 2116aed8b28ecb2866d6f5f87f7ebc8537fc4537
First added on: May 09, 2024